Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
1: not use carbapenem
2: no change in mortality risk
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
35%
(medium)
Question Stats:
28% (02:02) correct
72%
(02:15)
wrong
based on 548
sessions
History
Date
Time
Result
Not Attempted Yet
A study was conducted to determine the effects of using a specific type of antibiotic, carbapenems, on critically ill patients with bacterial infections. The researchers divided the patients into two groups: those who received carbapenems and those who did not. The study had two main goals: to determine whether carbapenems reduced mortality and to assess whether prolonged carbapenem use increased the likelihood of developing multidrug-resistant (MDR) pathogens.
Results indicated that there was no significant difference in mortality between the two groups, but patients who received carbapenems for a longer duration were more likely to have new MDR pathogens detected.
Statement: If a doctor wanted to minimize the likelihood of developing MDR pathogens, she would be more likely to X on critically ill patients with bacterial infections, which would result in Y as compared to carbapenem treatment.
Select for __1__ and for __2__ the options that complete the statement so that it most accurately reflects the information provided. Make only two selections, one in each column.
Results indicated that there was no significant difference in mortality between the two groups, but patients who received carbapenems for a longer duration were more likely to have new MDR pathogens detected.
Statement: If a doctor wanted to minimize the likelihood of developing MDR pathogens, she would be more likely to X on critically ill patients with bacterial infections, which would result in Y as compared to carbapenem treatment.
Select for __1__ and for __2__ the options that complete the statement so that it most accurately reflects the information provided. Make only two selections, one in each column.
| 1 | 2 | |
| use carbapenems | ||
| not use carbapenem | ||
| an increase in mortality risk | ||
| a decrease in mortality risk | ||
| no change in mortality risk |
ShowHide Answer
Official Answer
1: not use carbapenem
2: no change in mortality risk
15 Apr 2025, 07:05
Kudos
Bookmarks
Official Solution:
1. What would the doctor do to minimize the likelihood of developing MDR pathogens?
• The study says prolonged carbapenem use increases MDR pathogens.
• To minimize this risk, the doctor would be more likely to not use carbapenem.
Correct selection for 1 → not use carbapenem
2. What would be the impact on mortality compared to carbapenem treatment?
• The study says there was no significant difference in mortality between the group that received carbapenems and the group that did not.
Correct selection for 2 → no change in mortality risk
Correct answer:
1 "not use carbapenem"
2 "no change in mortality risk"
Bunuel
1. What would the doctor do to minimize the likelihood of developing MDR pathogens?
• The study says prolonged carbapenem use increases MDR pathogens.
• To minimize this risk, the doctor would be more likely to not use carbapenem.
Correct selection for 1 → not use carbapenem
2. What would be the impact on mortality compared to carbapenem treatment?
• The study says there was no significant difference in mortality between the group that received carbapenems and the group that did not.
Correct selection for 2 → no change in mortality risk
Correct answer:
1 "not use carbapenem"
2 "no change in mortality risk"
General Discussion
16 Sep 2024, 17:28
Kudos
Bookmarks
Here's the official solution:
There are two pieces of relevant information in the prompt:
To minimize the risk of detecting MDR pathogens (which was linked to prolonged carbapenem use), the doctor would likely choose not to use carbapenem. Regarding mortality, the study states there was no change in mortality risk between those who did and did not use carbapenems.
Thus, the best selections are:
There are two pieces of relevant information in the prompt:
- Carbapenem use and mortality: The study shows no significant difference in mortality between the group that received carbapenems and the group that did not.
- Carbapenem use and MDR pathogens: The study found that a longer duration of carbapenem use increased the risk of detecting multidrug-resistant (MDR) pathogens.
To minimize the risk of detecting MDR pathogens (which was linked to prolonged carbapenem use), the doctor would likely choose not to use carbapenem. Regarding mortality, the study states there was no change in mortality risk between those who did and did not use carbapenems.
Thus, the best selections are:
- X: Not use carbapenem
- Y: No change in mortality risk
